Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001140361-12-016054
Filing Date
2012-03-16
Accepted
2012-03-15 18:43:17
Documents
15
Period of Report
2011-12-31

Document Format Files

Seq Description Document Type Size
1 REXAHN PHARMACEUTICALS, INC 10-K 12-31-2011 form10k.htm 10-K 2653483
2 EXHIBIT 12.1 ex12_1.htm EX-12.1 30987
3 EXHIBIT 23 ex23.htm EX-23 3586
4 EXHIBIT 24 ex24.htm EX-24 21696
5 EXHIBIT 31.1 ex31_1.htm EX-31.1 16722
6 EXHIBIT 31.2 ex31_2.htm EX-31.2 15981
7 EXHIBIT 32.1 ex32_1.htm EX-32.1 10032
8 EXHIBIT 32.2 ex32_2.htm EX-32.2 9728
15 IMAGE image.jpg GRAPHIC 83413
  Complete submission text file 0001140361-12-016054.txt   8056603

Data Files

Seq Description Document Type Size
9 INSTANCE DOCUMENT rnn-20111231.xml EX-101.INS 1319246
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rnn-20111231.xsd EX-101.SCH 20747
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rnn-20111231_cal.xml EX-101.CAL 38940
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rnn-20111231_def.xml EX-101.DEF 55447
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rnn-20111231_lab.xml EX-101.LAB 177899
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rnn-20111231_pre.xml EX-101.PRE 118320
Mailing Address 15245 SHADY GROVE ROAD, SUITE 455 ROCKVILLE MD 20850
Business Address 15245 SHADY GROVE ROAD, SUITE 455 ROCKVILLE MD 20850 2402685300
REXAHN PHARMACEUTICALS, INC. (Filer) CIK: 0001228627 (see all company filings)

EIN.: 113516358 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-34079 | Film No.: 12695374
SIC: 2834 Pharmaceutical Preparations